Alberta Investment Management Corp (AIMCo)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-17,606
| Closed | -$342K | – | 1218 |
|
|
2023
Q2 | $342K | Sell |
17,606
-1,992
| -10% | -$38.7K | ﹤0.01% | 1025 |
|
|
2023
Q1 | $556K | Hold |
19,598
| – | – | 0.01% | 939 |
|
|
2022
Q4 | $573K | Sell |
19,598
-861
| -4% | -$25.2K | 0.01% | 904 |
|
|
2022
Q3 | $541K | Buy |
20,459
+4,632
| +29% | +$122K | ﹤0.01% | 1056 |
|
|
2022
Q2 | $703K | Hold |
15,827
| – | – | 0.01% | 986 |
|
|
2022
Q1 | $783K | Buy |
15,827
+7,714
| +95% | +$382K | ﹤0.01% | 1038 |
|
|
2021
Q4 | $413K | Buy |
+8,113
| New | +$413K | ﹤0.01% | 903 |
|
|
2020
Q3 | – | Sell |
-8,400
| Closed | -$403K | – | 1169 |
|
|
2020
Q2 | $403K | Sell |
8,400
-8,100
| -49% | -$389K | ﹤0.01% | 883 |
|
|
2020
Q1 | $759K | Sell |
16,500
-6,250
| -27% | -$288K | 0.01% | 634 |
|
|
2019
Q4 | $1.37M | Sell |
22,750
-15,450
| -40% | -$928K | 0.01% | 591 |
|
|
2019
Q3 | $2.16M | Buy |
38,200
+4,989
| +15% | +$282K | 0.02% | 484 |
|
|
2019
Q2 | $1.85M | Buy |
33,211
+8,911
| +37% | +$496K | 0.02% | 497 |
|
|
2019
Q1 | $1.23M | Buy |
24,300
+13,500
| +125% | +$682K | 0.01% | 567 |
|
|
2018
Q4 | $435K | Sell |
10,800
-5,200
| -33% | -$209K | ﹤0.01% | 707 |
|
|
2018
Q3 | $1.11M | Sell |
16,000
-6,500
| -29% | -$451K | 0.01% | 596 |
|
|
2018
Q2 | $1.7M | Sell |
22,500
-7,500
| -25% | -$567K | 0.01% | 484 |
|
|
2018
Q1 | $1.58M | Sell |
30,000
-52,700
| -64% | -$2.78M | 0.01% | 478 |
|
|
2017
Q4 | $4.42M | Buy |
82,700
+26,800
| +48% | +$1.43M | 0.04% | 366 |
|
|
2017
Q3 | $3.33M | Buy |
+55,900
| New | +$3.33M | 0.03% | 387 |
|